Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Provider Notice issued 02/29/08

Preferred Drug List – Basal Insulin

To:​ ​Medical Assistance Providers
​Date: ​February 29, 2008
​Re:

Preferred Drug List – Basal Insulin​

In October 2007, Levemir® replaced Lantus® as HFS’ preferred basal insulin.  Levemir® multi-dose vials are covered without a requirement for Prior Authorization (PA); a PA is required for Levemir® Flexpens.

HFS identified patients who were established on Lantus® and provided them a temporary prior authorization override through March 31, 2008, to allow time for them to transition to the new preferred product, Levemir® multi-dose vials.  During this transition period, if a prescriber feels that there is a medical reason that a patient cannot switch to Levemir®, the prescriber will need to submit a PA request for Lantus® multi-dose vials for that patient. 

Prior approval may be requested by calling 1-800-252-8942, or by fax at 217-524-0404 or 217-524-7264.  Prior approval forms may be found at:

http://www.illinois.gov/hfs/MedicalProviders/Pharmacy/Pages/DrugPriorApprovalInformation.aspx

Theresa A. Eagleson, Administrator

Division of Medical Programs